Chengdu Easton Biopharmaceuticals Co., Ltd. Stock: price and insider trades · China
苑东生物
Chengdu Easton Biopharmaceuticals Co., Ltd.: what insiders have been doing
Only a handful of insider records exist for Chengdu Easton Biopharmaceuticals Co., Ltd., the last one from 28 July 2025, too few to describe a trend. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,485,100 shares100.0% of flowA股XSHGSSE:173000009287910270
1 of 1 declaration
About Chengdu Easton Biopharmaceuticals Co., Ltd.
苑东生物 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
